Tesamorelin

Overview

Tesamorelin is another GHRH analog, but it stands out in this category for having gone through formal clinical trials and FDA approval, specifically for reducing excess abdominal visceral fat in a defined patient population. That approval history makes it one of the better-studied peptides for this particular effect, though its approved use is narrower than the general growth-hormone-boosting reputation this category has.

Dosing

See the general Dosing Guide for reconstitution and administration basics.